Pressure BioSciences Announces Plan to Acquire Cannaworx, Inc.
April 29, 2020
Pressure BioSciences signed a binding letter of intent to merge with Cannaworx, Inc., bringing Cannaworx's portfolio of hemp-derived CBD, cosmeceutical, nutraceutical and veterinary products into PBI's public company. Post-transaction, Cannaworx products are expected to utilize PBI's Ultra Shear Technology to create stable, highly bioabsorbable nanoemulsions and to accelerate product commercialization across consumer, veterinary and agricultural markets.
- Buyers
- Pressure BioSciences, Inc.
- Targets
- Cannaworx, Inc.
- Industry
- Biotechnology
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Pressure BioSciences Acquires Uncle Bud's
January 11, 2024
Consumer Products
Pressure BioSciences, Inc. (PBIO) entered into a definitive agreement to acquire natural health and wellness brand Uncle Bud's. The deal will forward-integrate PBIO's UltraShear technology into Uncle Bud's topical, personal care, beverage and pet product lines; Uncle Bud's stockholders will receive preferred PBIO stock and potential earnout shares based on 2024 results.
-
Cannabinoid Biosciences Acquires CannabidiolHemp
November 25, 2019
Consumer Products
Cannabinoid Biosciences, Inc., a California-based biopharmaceutical subsidiary of Kid Castle, has acquired CannabidiolHemp (CannabidiolHemp.net), a CBD quality aggregator and validator. The purchase is the first of multiple planned acquisitions intended to build a vertically integrated CBD distribution and supply-chain business across the United States and Canada.
-
Nexus Agriscience Acquires Hemp Division and IP Portfolio from Biotech Institute
January 27, 2026
Biotechnology
Nexus Agriscience has acquired the hemp division and intellectual property portfolio of Biotech Institute, internalizing genetics, germplasm, and research talent to expand its molecular farming platform. The transaction brings issued and pending patents, proprietary germplasm, seed inventory, and key personnel into Nexus to accelerate development of hemp-derived natural ingredients for flavor, fragrance, and functional markets.
-
Puration, Inc. Acquires CBD Sun Care Product Business
June 4, 2020
Consumer Products
Puration, Inc. (PURA) announced the acquisition of a CBD-infused sun care product business as part of a broader campaign to acquire CBD-infused beverage, edible and topical brands. The deal expands PURA's consumer product portfolio and leverages its licensed cannabis extraction technology to enter the estimated $8.5 billion global sun care market.
-
22nd Century Group Acquires RX Pharmatech Ltd
January 24, 2023
Food & Beverage
22nd Century Group, through its GVB Biopharma business, acquired UK-based RX Pharmatech Ltd, a distributor of cannabinoid/CBD products and holder of numerous U.K. novel food applications. The deal includes $650,000 up-front in cash and stock plus a three-year equity earn-out tied to revenue milestones and aims to strengthen 22nd Century's access and distribution in the U.K. and EU consumer CBD market.
-
Isracann Biosciences to Acquire Praesidio Health
February 23, 2022
Biotechnology
Isracann Biosciences Inc. entered into a binding letter of intent to acquire Canadian medical research company Praesidio Health Inc. under a stock transaction valued at approximately CAD 4.0 million. Praesidio develops and validates evidence-based natural health medicines (including formulations with cannabinoids and/or psilocybin) for conditions such as urological disorders, anxiety/stress, immune support and sleep.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.